| Galderma Launches New Cetaphil(R) SPF 50 Product
Cetaphil(R) UVA/UVB Defense SPF 50 has also been awarded the Skin Cancer Foundation Seal of Recommendation. The Skin Cancer Foundation recommends this product as an effective UV facial sunscreen and as an effective aid in the prevention of sun induced damage to the skin including sunburn and possibly, premature aging. It is important to use proper UVA/UVB filters to help prevent sunburn and other skin damage. The lightweight formula of the Cetaphil(R) UVA/UVB Defense SPF 50 hydrates the skin to avoid evaporation and absorbs quickly, leaving no filmy white residue. It is fragrance free, non-irritating and non-comedogenic, so it won't clog pores, making it a suitable choice for those with acne, rosacea or melasma and other skin related conditions, where a hydrating formula with SPF protection is recommended.
'Master switch' gene could turn off cancer
'Switching on' the gene was enough to halt the development of the tumours, including Merkel cell carcinoma, a rare but deadly form of skin cancer. The Belgian researchers, whose findings are published in the online journal PLoS Biology, said the genes were 'important brakes on malignant transformation'. Scientists also believe that the same group of genes might play a role in the early stages of breast cancer development. .
Featured Article Pain Relief10 Tips to Overcome Morning Stiffness
He specializes in Master Tung Acupuncture to help patients with musculoskeletal disorders, pain, infertility, cancer treatment related side effects, cardiovascular problems, diabetes, and thyroid issues. Dr. Chu is a contributing editor and on the advisory board for The Healthy Back Institute.] .
Plums poised to give blueberries run for the money
The team examined the full content of plums and peaches, then tested the effect of the compounds they found on breast cancer cells and cholesterol in the lab. �We screened the varieties again with the biological assays,� Cisneros said. �And that had never been done before, because it is expensive and a lot of work. But that investment is small in terms of the information we got, and how it can be used now for breeding efforts to produce even better fruit.� Byrne noted, for example, that one benefit the team found was that the phytonutrients in plums inhibited in vitro breast cancer growth without adversely affecting normal cell growth. He said this type of research needs further study but is an indication that breeders ultimately will be able to produce new crop varieties with the best ratio of various phytochemicals to have an impact on disease prevention and inhibition.
Enhanced skin cancer risk linked with to cell defects
Telomere dysfunction in skin cells can lead to increased skin cancer risk and pigmentation, it has found. Researchers from Spain investigated the molecular mechanisms underlying skin cell telomere dysfunction using a mouse model of Xeroderma Pigmentosum (XP), a disease in which patients have increased sensitivity to ultraviolet (UV) radiation. Their studies revealed that these mice have impaired skin cell regeneration, and that limiting the activity of a tumour suppressor signalling protein, p53, restores cell regeneration and reduces hyperpigmentation. Surprisingly, limiting p53 activity also advances the progression of skin cancers. This study establishes a link between telomere dysfunction, cancer progression and the dysfunction of DNA repair mechanisms in XP patients. Understanding the pathways which control cell regeneration and cancer progression in these patients will not only aid in treatments for XP patients, but can likewise provide clues on how to target and better treat other cases of skin cancer.
Dance for Dicus Raised $5000+ for Will Dicus Fund
He has undergone years of cancer treatment to fight the disease. The dance was headed up by 20-year-old Caldwell Community College and Technical Institute Watauga Campus Student Body President Brent Whitley. Whitley said he first learned about the Dicus family while serving as a volunteer in the emergency room at Watauga Medical Center. Whitley explained that he found out about Will and his family’s ongoing battle against cancer after he asked about a flyer for the Dicus Medical Fund. .
DOR BioPharma Announces Potential $30 Million North American
The first trial was a 60-patient Phase 2 single-center clinical trial conducted at the Fred Hutchinson Cancer Research Center. The second trial was a 129-patient pivotal Phase 3 multi-center clinical trial of orBec(R) conducted at 16 leading bone marrow/stem cell transplantation centers in the US and France. Although orBec(R) did not achieve statistical significance in the primary endpoint of its pivotal trial, namely median time-to-treatment failure through Day 50 (p-value 0.1177), orBec(R) did achieve statistical significance in other key secondary endpoints such as the proportion of patients free of GVHD at Day 50 (p-value 0.05) and Day 80 (p-value 0.005) and the median time to treatment failure through Day 80 (p-value 0.0226), as well as a 66% reduction in mortality among patients randomized to orBec(R) at 200 days post-transplant with only 5 patient (8%) deaths in the orBec(R) group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139).
Curator threatens nil by mouth to save rare specimens
Last year administrators at Sydney Hospital decided to destroy the collection, which is on display at the Lucy Osburn-Nightingale Foundation Museum in the hospital. A series of letters, emails and minutes from meetings leaked to the Herald show that the chief executive of South Eastern Sydney Illawarra Area Health Service, Terry Clout, ordered the disposal of the specimens, which include rare fungal diseases, kidney and bladder stones and all types of brain cancer. Months earlier, Ms Wrobel was told the museum would be closed and the space, which neighbours Parliament House, would be converted into offices for health officials. Pleas by Ms Wrobel, the chairman of the foundation, Barry Shepherd, and numerous pathologists, including Stan McCarthy, an eminent specialist from RPA, failed to convince Mr Clout of the invaluable nature of the collection.
Study sees no eye cancer risk from mobile phones
Melanoma is an aggressive form of cancer that can spread quickly. It arises in cells that produce the pigment called melanin that gives skin its color. The eyes also have cells that produce melanin. Melanoma of the eye is rare. The condition also is called uveal melanoma. The issue of whether long-term use of cell phones can cause cancer, in particular brain tumors, has been a hot topic, but most studies examining the matter have found no such association. "We did not corroborate our previous results that showed an increased risk of uveal melanoma among regular mobile phone users," Dr. Andreas Stang of the Martin-Luther-University of Halle-Wittenberg in Germany wrote in the journal. "Uncertainty exists about the role, if any, of radio waves transmitted by radio sets or mobile phones in human carcinogenesis (cancer development)," they added.
Kicking off their battle to put an end to cancer
The palms of her hands and soles of her feet turned bright red and the skin began to peel off. After 11 years of illness, an oncologist discovered through tests she had a tumor in her pancreas. A surgeon removed the mass and two-thirds of her spleen. The lifespan for someone with her rare cancer is not quite five years. She was diagnosed 18 years ago. A breakthrough in her condition came when the couple went on an eight-day cruise. She was out in the sun and began to feel better than she had in years. When she returned to Goldsboro, she told her doctor about the improvement. Now she takes regular doses of vitamin D, which she says have made her feel like a new person. "I'm not in remission, but I enjoy every minute of feeling better," she said.
|
